Clinical Trials Browser

Phase 1/2 × Ovarian Neoplasms × Celecoxib × Clear all

NCT02432378 2025-06-19

Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Phase 1/2 Terminated

Ovarian Neoplasms